Selwyn M. MD Vickers - 08 Jun 2022 Form 4 Insider Report for Forma Therapeutics Holdings, Inc. (FMTX)

Role
Director
Signature
/s/ Jeannette Potts, as Attorney-in-Fact
Issuer symbol
FMTX
Transactions as of
08 Jun 2022
Transactions value $
$0
Form type
4
Filing time
09 Jun 2022, 17:35:33 UTC
Previous filing
21 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FMTX Common Stock Award $0 +4,500 +164% $0 7,250 08 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FMTX Stock Option (Right to Buy) Award $0 +6,750 $0 6,750 08 Jun 2022 Common Stock 6,750 $6.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
F2 This option shall vest and become exercisable in full upon the earlier to occur of (i) June 8, 2023 and (ii) the next annual meeting of the Issuer's stockholders.